Fleming Patrick, Zhou Stephanie, Bobotsis Robert, Lynde Charles
1 Division of Dermatology, University of Toronto, Toronto, Canada.
2 MD Program, Faculty of Medicine, University of Toronto, Toronto, Canada.
J Cutan Med Surg. 2017 Sep/Oct;21(5):408-417. doi: 10.1177/1203475417708166. Epub 2017 May 16.
There are currently several reputable guidelines on the treatment of actinic keratosis (AK) from groups in Canada, the United Kingdom, and Europe. These recommendations, based on evidence or expert consensus, offer clinicians a variety of treatment options for the different clinical presentations of AKs. Although the guidelines are similar in some regards, variations exist in treatment options, duration, and strength of recommendation. Some guidelines also lack input on specific therapies and certain types of AK, such as hypertrophic or thin presentations. The purpose of this article is to review and compare guidelines published by Canadian, UK, and European groups for the management of AKs in patients.
目前，加拿大、英国和欧洲的一些组织发布了关于光化性角化病（AK）治疗的多项权威指南。这些基于证据或专家共识的建议，为临床医生针对不同临床表现的AK提供了多种治疗选择。尽管这些指南在某些方面相似，但在治疗选择、持续时间和推荐强度方面存在差异。一些指南还缺乏对特定疗法和某些类型AK（如肥厚型或薄型表现）的相关内容。本文的目的是回顾和比较加拿大、英国和欧洲组织发布的关于患者AK管理的指南。
